CMIC HOLDINGS Co., Ltd. / Japan
CMIC Group pioneered the CRO business in Japan over 28 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward. CMIC offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications with over 7,000 employees.
Orphan drug which is in late stage development or marketed outside Japan. OrphanPacific, CMIC's affiliate, look for in licensing candidates.
CRO (clinical and non-clinical), CMO, CSO services and MA holding as fee for service in Japan.